Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors

Inhibitors

Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
More
Less

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
VU 0357121
CAS:
433967-28-3
MF:
C17H17F2NO2
Structure:
Chemical Name:
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea
CAS:
1207360-89-1
MF:
C24H32N6O3
Structure:
Chemical Name:
Nepicastat hydrochloride
CAS:
170151-24-3
MF:
C14H16ClF2N3S
Structure:
Chemical Name:
BMN 673
CAS:
1207456-01-6
MF:
C19H14F2N6O
Structure:
Chemical Name:
Tezacaftor
CAS:
1152311-62-0
MF:
C26H27F3N2O6
Structure:
Chemical Name:
OSI-420
CAS:
183320-51-6
MF:
C21H22ClN3O4
Structure:
Chemical Name:
MK8245
CAS:
1030612-90-8
MF:
C17H16BrFN6O4
Structure:
Chemical Name:
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS:
475488-23-4
MF:
C28H31N5O
Structure:
Chemical Name:
PKI-402
CAS:
1173204-81-3
MF:
C29H34N10O3
Structure:
Chemical Name:
Ciproxifan
CAS:
184025-18-1
MF:
C16H18N2O2
Structure:
Chemical Name:
Zibotentan (ZD4054)
CAS:
186497-07-4
MF:
C19H16N6O4S
Structure:
Chemical Name:
BRL 54443
CAS:
57477-39-1
MF:
C14H18N2O
Structure:
Chemical Name:
Marimastat
CAS:
154039-60-8
MF:
C15H29N3O5
Structure:
Chemical Name:
Galeterone
CAS:
851983-85-2
MF:
C26H32N2O
Structure:
Chemical Name:
ICG-001
CAS:
780757-88-2
MF:
C33H32N4O4
Structure:
Chemical Name:
Nutlin 3a
CAS:
675576-98-4
MF:
C30H30Cl2N4O4
Structure:
Chemical Name:
2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO-
CAS:
252935-94-7
MF:
C20H17Cl2N9O2
Structure:
Chemical Name:
4SC-201
CAS:
864814-88-0
MF:
C16H19N3O4S
Structure:
Chemical Name:
R788(Fostamatinib disodium)
CAS:
1025687-58-4
MF:
C23H27FN6NaO9P
Structure:
Chemical Name:
AVP-AEW541
CAS:
475489-16-8
MF:
C27H29N5O
Structure:
Chemical Name:
CHIR-124
CAS:
405168-58-3
MF:
C23H22ClN5O
Structure:
Chemical Name:
Erteberel (LY500307)
CAS:
533884-09-2
MF:
C18H18O3
Structure:
Chemical Name:
Onalespib
CAS:
912999-49-6
MF:
C24H31N3O3
Structure:
Chemical Name:
TAE226 (NVP-TAE226)
CAS:
761437-28-9
MF:
C23H25ClN6O3
Structure:
Chemical Name:
Tenovin-6
CAS:
1011557-82-6
MF:
C25H34N4O2S
Structure:
Chemical Name:
BMS-265246
CAS:
582315-72-8
MF:
C18H17F2N3O2
Structure:
Chemical Name:
PF-3758309
CAS:
898044-15-0
MF:
C25H30N8OS
Structure:
Chemical Name:
AZD3514
CAS:
1240299-33-5
MF:
C25H32F3N7O2
Structure:
Chemical Name:
KPT-185
CAS:
1333151-73-7
MF:
C16H16F3N3O3
Structure:
Chemical Name:
ALK/IGF1R inhibitor
CAS:
1356962-20-3
MF:
C24H25ClN6O
Structure:
Chemical Name:
Ribociclib
CAS:
1211441-98-3
MF:
C23H30N8O
Structure:
Chemical Name:
GLPG0634
CAS:
1206101-20-3
MF:
C23H18N6O2
Structure:
Chemical Name:
WH-4-023
CAS:
837422-57-8
MF:
C32H36N6O4
Structure:
Chemical Name:
PJ-34
CAS:
344458-19-1
MF:
C17H17N3O2
Structure:
Chemical Name:
Pifithrin-μ
CAS:
64984-31-2
MF:
C8H7NO2S
Structure:
Chemical Name:
ZM 306416
CAS:
690206-97-4
MF:
C16H13ClFN3O2
Structure:
Chemical Name:
Alizapride hydrochloride
CAS:
59338-87-3
MF:
C16H22ClN5O2
Structure:
Chemical Name:
Dexmedetomidine
CAS:
113775-47-6
MF:
C13H16N2
Structure:
Chemical Name:
TPCA-1
CAS:
507475-17-4
MF:
C12H10FN3O2S
Structure:
Chemical Name:
GW0742
CAS:
317318-84-6
MF:
C21H17F4NO3S2
Structure:
Chemical Name:
5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide
CAS:
868273-06-7
MF:
C24H28ClN3O
Structure:
Chemical Name:
5-(2-Oxo-2-phenylethoxy)-3,4-dihydroisoquinolin-1(2H)-one
CAS:
1048371-03-4
MF:
C17H13NO3
Structure:
Chemical Name:
1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone
CAS:
314245-33-5
MF:
C18H21FN2O
Structure:
Chemical Name:
R406
CAS:
841290-81-1
MF:
C28H29FN6O8S
Structure:
Chemical Name:
A66
CAS:
1166227-08-2
MF:
C17H23N5O2S2
Structure:
Chemical Name:
AMG-208
CAS:
1002304-34-8
MF:
C22H17N5O2
Structure:
Chemical Name:
KRN 633
CAS:
286370-15-8
MF:
C20H21ClN4O4
Structure:
Chemical Name:
TAK-733
CAS:
1035555-63-5
MF:
C17H15F2IN4O4
Structure:
Chemical Name:
R428
CAS:
1037624-75-1
MF:
C30H34N8
Structure:
Chemical Name:
GSK 525762A
CAS:
1260907-17-2
MF:
C22H22ClN5O2
Structure:
Chemical Name:
PI3K/HDAC Inhibitor
CAS:
1339928-25-4
MF:
C23H24N8O4S
Structure:
Chemical Name:
AGI6780
CAS:
1432660-47-3
MF:
C21H18F3N3O3S2
Structure:
Chemical Name:
BMS 833923
CAS:
1059734-66-5
MF:
C30H27N5O
Structure:
Chemical Name:
RKI1447
CAS:
1342278-01-6
MF:
C16H14N4O2S
Structure:
Chemical Name:
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon
CAS:
194413-58-6
MF:
C15H14N2O
Structure:
Chemical Name:
SL 327
CAS:
305350-87-2
MF:
C16H12F3N3S
Structure:
Chemical Name:
N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide
CAS:
717906-29-1
MF:
C22H21F3N6O3S
Structure:
Chemical Name:
JNJ-26481585
CAS:
875320-29-9
MF:
C21H26N6O2
Structure:
Chemical Name:
MK 3207 hydrochloride
CAS:
957116-20-0
MF:
C31H30ClF2N5O3
Structure:
Chemical Name:
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
CAS:
801312-28-7
MF:
C27H26N4O5S
Structure:
Chemical Name:
VS-5584
CAS:
1246560-33-7
MF:
C17H22N8O
Structure:
Chemical Name:
iOWH-032
CAS:
1191252-49-9
MF:
C22H15Br2N3O4
Structure:
Chemical Name:
GNF5
CAS:
778277-15-9
MF:
C20H17F3N4O3
Structure:
Chemical Name:
E-64C
CAS:
76684-89-4
MF:
C15H26N2O5
Structure:
Chemical Name:
(Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE
CAS:
403811-55-2
MF:
C12H11NOS2
Structure:
Chemical Name:
(R,S)-AM1241
CAS:
444912-48-5
MF:
C22H22IN3O3
Structure:
Chemical Name:
SPLITOMICIN
CAS:
5690-03-9
MF:
C13H10O2
Structure:
Chemical Name:
CP-724714
CAS:
537705-08-1
MF:
C27H27N5O3
Structure:
Chemical Name:
VX-222
CAS:
1026785-59-0
MF:
C25H35NO4S
Structure:
Chemical Name:
OSI-930
CAS:
728033-96-3
MF:
C22H16F3N3O2S
Structure:
Chemical Name:
KU-60019
CAS:
925701-49-1
MF:
C30H33N3O5S
Structure:
Chemical Name:
9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one
CAS:
1124329-14-1
MF:
C24H32N6O3
Structure:
Chemical Name:
N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide
CAS:
312917-14-9
MF:
C20H16N2OS
Structure:
Chemical Name:
4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide
CAS:
908112-43-6
MF:
C23H27F3N4O3
Structure:
Chemical Name:
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one
CAS:
1223001-51-1
MF:
C24H15F3N4O
Structure:
Chemical Name:
Torin 1
CAS:
1222998-36-8
MF:
C35H28F3N5O2
Structure:
Chemical Name:
BIX 02189
CAS:
1094614-85-3
MF:
C27H28N4O2
Structure:
Chemical Name:
N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea
CAS:
1020172-07-9
MF:
C30H28FN7O3
Structure:
Chemical Name:
Octanoic acid, 6,8-bis[(phenylMethyl)thio]-
CAS:
95809-78-2
MF:
C22H28O2S2
Structure:
Chemical Name:
A-674563
CAS:
552325-73-2
MF:
C22H22N4O
Structure:
Chemical Name:
PF-04929113
CAS:
908115-27-5
MF:
C25H30F3N5O4
Structure:
Chemical Name:
NVP-BGT226
CAS:
1245537-68-1
MF:
C28H25F3N6O2.C4H4O4
Structure:
Chemical Name:
BAY 80-6946 (Copanlisib)
CAS:
1032568-63-0
MF:
C23H28N8O4
Structure:
Chemical Name:
Filgotinib
CAS:
1206161-97-8
MF:
C21H23N5O3S
Structure:
Chemical Name:
KGN
CAS:
4727-31-5
MF:
C20H15NO3
Structure:
Chemical Name:
PCI 34051
CAS:
950762-95-5
MF:
C17H16N2O3
Structure:
Chemical Name:
BRL 15572 HYDROCHLORIDE
CAS:
193611-72-2
MF:
C25H28Cl2N2O
Structure:
Chemical Name:
Oprozomib
CAS:
935888-69-0
MF:
C25H32N4O7S
Structure:
Chemical Name:
Skepinone-L
CAS:
1221485-83-1
MF:
C24H21F2NO4
Structure:
Chemical Name:
NVP-BVU 972
CAS:
1185763-69-2
MF:
C20H16N6
Structure:
Chemical Name:
GSK 343
CAS:
1346704-33-3
MF:
C31H39N7O2
Structure:
Chemical Name:
TAK-632
CAS:
1228591-30-7
MF:
C27H18F4N4O3S
Structure:
Chemical Name:
PURVALANOL A
CAS:
212844-53-6
MF:
C19H25ClN6O
Structure:
Chemical Name:
S- (+)-Rolipram
CAS:
85416-73-5
MF:
C16H21NO3
Structure:
Chemical Name:
(-)-MK-801 MALEATE
CAS:
121917-57-5
MF:
C20H19NO4
Structure:
Chemical Name:
REVERSINE
CAS:
656820-32-5
MF:
C21H27N7O
Structure:
Chemical Name:
SCRIPTAID
CAS:
287383-59-9
MF:
C18H18N2O4
Structure:
Chemical Name:
TG003
CAS:
300801-52-9
MF:
C13H15NO2S
Structure:
Chemical Name:
TYRPHOSTIN AG 1024
CAS:
65678-07-1
MF:
C14H13BrN2O
Structure:
Chemical Name:
LDN-57444
CAS:
668467-91-2
MF:
C17H11Cl3N2O3